Back to Journals » Cancer Management and Research » Volume 11

Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway

Total article views   HTML views PDF downloads Totals
6,054 Dovepress* 5,352+ 853 6,205
PubMed Central* 702 210 912
Totals 6,054 1,063 7,117
*Since 17 September 2019

View citations on PubMed Central and Google Scholar